Contactin 2 and contactin-associated protein 2 antibodies in patients with multiple sclerosis and clinically isolated syndrome
Päätekijät: | Nytrova, P, Waters, P, Horakova, D, Hacohen, Y, Kalincik, T, Zbornikova, P, Blahova, J, Krasensky, J, Vaneckova, M, Havrdova, E, Wandinger, K, Vincent, A |
---|---|
Aineistotyyppi: | Conference item |
Julkaistu: |
2012
|
Samankaltaisia teoksia
-
No evidence for association of autism with rare heterozygous point mutations in Contactin-Associated Protein-Like 2 (CNTNAP2), or in Other Contactin-Associated Proteins or Contactins.
Tekijä: John D Murdoch, et al.
Julkaistu: (2015-01-01) -
Association of leucine-rich glioma inactivated protein 1, contactin-associated protein 2, and contactin 2 antibodies with clinical features and patient-reported pain in acquired neuromyotonia
Tekijä: Vincent, A, et al.
Julkaistu: (2018) -
Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
Tekijä: Becker, E, et al.
Julkaistu: (2012) -
Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
Tekijä: Becker, E, et al.
Julkaistu: (2012) -
Implication of Contactins in Demyelinating Pathologies
Tekijä: Ilias Kalafatakis, et al.
Julkaistu: (2021-01-01)